.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Added evidence points to importance of bone marrow-derived progenitor in CNV

September 1, 2004

Fort Lauderdale, FL-Studies in a preclinical model of experimentally induced choroidal neovascularization (CNV) indicate that circulating bone marrow-derived cells contribute significantly to the vascular and inflammatory components of CNV. That finding has potential implications for understanding of the pathophysiology of CNV associated with age-related macular degeneration (AMD) as well as for suggesting new therapeutic targets, according to the researchers from the Bascom Palmer Eye Institute, University of Miami.